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Background
Simple renal cysts are the most commonly detected type of renal mass and usually do 
not require treatment (Clayman et al. 1984). However, when large renal cysts are associ-
ated with flank or back pain, hypertension or renal calyceal or pelvic obstruction, they 
require treatment (Brown et al. 1995). Symptomatic renal cysts can be treated by a vari-
ety of surgical and interventional managements such as percutaneous aspiration with or 
without sclerotherapy (Amar and Das 1984; Agarwal et al. 2012; Zerem et al. 2008; el-
Diasty et al. 1995). Surgical treatment and laparoscopic deroofing are more invasive, and 
thus necessitate general anesthesia with the accompanying potential operative morbidity 
and possible complications. Compared to other surgical treatment methods, percutane-
ous needle aspiration and sclerotherapy are less invasive (Agarwal et al. 2012). Although 
various sclerosants have been used, alcohol is the most commonly used sclerosing mate-
rial for cyst ablation (Amar and Das 1984; Mohsen and Gomha 2005; Kwon et al. 2007; 
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Choi et al. 2009; Egilmez et al. 2007). However, alcohol is related to potential compli-
cations such as pain, fever, a drunken state, shock, loss of consciousness, and femoral 
nerve injury (Kim et al. 2004; Ashraf et al. 2012).
Acetic acid has been used as the sclerosant that induces coagulation necrosis around 
the injection site in rat livers and in the treatment of small hepatocellular carcinomas 
<3 cm in humans (Ohnishi et al. 1994). A high long-term success rate, even at a low 
dose, was reported in one published study in the management of renal cysts (Yoo et al. 
2008). There are, however, only two studies that compared the effectiveness of ace-
tic acid and ethanol in the sclerotherapy of simple renal cysts (Cho et  al. 2008; Seo 
et al. 2000). However, in these studies, there was no attempt to compare the treatment 
session of each sclerosant. Therefore, we compared the efficacy and treatment session 




Between February 2004 and June 2013, 86 patients with simple renal cysts underwent 
ultrasonography (US) or fluoroscopy-guided percutaneous aspiration and injection of 
50 %-acetic acid (42 cysts) and 95 %-ethanol (44 cysts). Forty-nine patients were male 
and 37 were female. The average patient age was 61.1 years (range 14–84 years). Table 1 
shows the baseline characteristics of the two groups. All patients underwent US or com-
puted tomography (CT) before and after their sclerotherapy. The indications for inter-
ventional treatment were large cyst (>4 cm) (n = 49), enlarged cysts (n = 22), flank pain 
(n = 13), nausea (n = 1), and hydronephrosis (n = 1). The risk and benefits of and the 
alternatives to the procedure were explained to all patents, and informed consent for the 
procedure was obtained from all of the patients. This retrospective study was approved 
by our hospital’s institutional review board.
Table 1 Patients’ baseline characteristics
a Independent t test
b Chi square test
c Mann–Whitney U test
Variable Overall Group
Acetic acid Ethanol p value
Number (%) 86 (100.0) 42 (48.8) 44 (51.2)
Age 61.1 ± 11.0 59.7 ± 13.1 62.3 ± 8.5 0.2721a
Sex
 Male 49 (57.0) 22 (52.4) 27 (61.4) 0.400b
 Female 37 (43.0) 20 (47.6) 17 (38.6)
Cyst location
 Right 36 (41.9) 19 (45.2) 17 (38.6) 0.535b
 Left 50 (58.1) 23 (54.8) 27 (61.4)
Pretreatment volume (ml) 206.7 ± 242.1 194.9 ± 211.2 217.9 ± 270.3 0.116c
Follow-up period (days) 326.7 ± 296.6 727.2 ± 854.2 0.258a
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Procedures and analysis
We usually performed the US-guided sclerotherapy using 95 %-ethanol in the early stage 
of our study, although later we preferred to use fluoroscopic-guided sclerotherapy with 
50 %-acetic acid. The mean diameter of the renal cysts was determined on the initial US 
or CT images before the procedures. The volume of each renal cyst was calculated from 
images obtained before and after the treatment using the method described by Lin et al. 
(2005).
where l, w, and d are the geometric length, width, and depth of the cyst, respectively. The 
procedure was performed in all patients on an in-patient basis. The volume of the sclero-
sant used was 10–40 % of the calculated volume of the cyst. The maximum volume of the 
sclerosant was 75 and 100 mL for acetic acid and ethanol, respectively. All patients were 
monitored during the procedures, and no conscious sedation was required. Patients 
were placed in a prone position, and the location of the renal cyst was confirmed on 
US. After appropriate selection of the entry site, we used the Seldinger technique with 
an 8.5-Fr pigtail catheter. After opacification of the cyst so as to rule out any commu-
nication with the renal parenchyma, collecting system or perirenal space, a 50 %-acetic 
acid or 95 %-ethanol solution was injected via the 8.5-F catheter following aspiration of 
the fluid from the renal cyst. After clamping of the catheter, the patient was rolled into 
supine, prone, and lateral decubitus positions at 5-min interval in order to increase the 
contact between all surfaces of the cysts and the sclerosant. The type and amount of the 
sclerosant were determined according to the eight operators’ preference.
In the ethanol group, the sclerosant was then evacuated through the pigtail catheter 
and the catheter was left open for natural drainage following sclerotherapy. If the drain-
age was more than 10  mL per day, a second sclerotherapy session was performed the 
following day. The catheter was removed when the amount of daily drainage was <10 mL 
and when the cavity was seen to be collapsed on US. If the drainage was more than 
10 mL per day, an additional sclerotherapy session was performed the following day. In 
the acetic acid group, the sclerosant was evacuated through the pigtail catheter and the 
catheter was removed at the time of sclerotherapy as there was only a single sclerother-
apy session was according to the protocol for acetic-acid sclerotherapy.
The renal cyst volumes calculated on last follow-up US or CT images were compared 
with those calculated before sclerotherapy. Comparison of the treatment effects was 
evaluated by two end-points, i.e. the volume reduction rate (overall regression rate) and 
the response to the sclerosant. The volume-reduction rate was defined as ([calculated 
initial volume  −  calculated post-treatment volume]/calculated initial volume)  ×  100. 
The response to the sclerosant was classified as complete regression (<5 % of the initial 
volume), partial regression (≥5 to <50 % of the initial volume) or no regression (≥50 % 
of the initial volume). The number of treatment sessions was also compared, and we 
evaluated the linear association between the initial calculated volume of the cyst and the 
volume-reduction rate in each group. The patients’ medical records were also reviewed 
for procedure-related complications.
V = (l × w × d)× 0.523,
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Statistical analysis
The categorical variables were summarized by numbers and percentages and the 
numeric variables, by their mean  ±  SD (standard deviation). Differences in patients’ 
demographics were compared across the subgroups using the Chi square test or Fisher’s 
exact test for categorical variables and the independent t test or the Mann–Whitney U 
test for numeric variables, as appropriate. Correlations were tested using the non-par-
ametric Spearman’s rank correlation coefficient. p values <0.05 were considered signif-
icant. All statistical analyses were performed using SPSS21.0 (SPSS, Inc., Chicago, IL, 
USA).
Results
According to the patients’ baseline characteristics, there was no significant difference 
inpatient age, sex, cyst location (right or left), and the follow-up period after sclerother-
apy between the acetic acid and the ethanol groups (Table 1). Cytological examinations 
were negative for neoplastic cells in all patients.
The mean initial diameter of the renal cysts was 6.6 cm (range 2.9–12.3 cm) in the ace-
tic acid group and 7.0 cm (range 4.0–15.3 cm) in the ethanol group. The mean calculated 
initial volume of the renal cysts in the pre-treatment imaging study was 194.9 ± 211.2 ml 
in the 50 %-acetic acid group and 217.9 ± 270.3 ml in the 95 %-ethanol group (Table 1), 
and there was no statistically significant difference between the two groups (p = 0.116). 
The used volume of acetic acid was 31.34 ± 17.2 mL (mean ± SD; range 4–75), while the 
used volume of ethanol was an average of 53.5 ± 31.2 mL (mean ± SD; range 12–100).
Following the treatment, the calculated volume reduction rate was 94.1 ± 7.6 % in the 
50 %-acetic acid group and 94.7 ± 11.7 % in the 95 %-ethanol group. No statistical dif-
ference was observed between the two groups (p = 0.071). The rates of complete regres-
sion, partial regression, and no regression were 57.1 % (n = 24), 42.9 % (n = 18), and 0 %, 
respectively, for the acetic acid group, and 70.5 (n = 31), 25.0 (n = 11), and 4.5 % (n = 2), 
respectively, for the ethanol group. No statistical difference was observed between the 
two groups (p = 0.088) (Table 2).
For the volume reduction rate, the total number of procedures was 45 in the 42 
patients in the acetic acid group and 77 in the 44 patients in the ethanol group. For 
Table 2 Difference in  the clinical outcomes and  treatment session between  the patient 
groups
CR complete regression, PR partial regression, NR no regression
Volume reduction Group p value
Acetic acid (n = 42) Ethanol (n = 44)
Volume reduction rate (%) (mean ± SD) 94.1 ± 7.6 94.7 ± 11.7 0.088
CR (>95 %) 24 (57.1) 31 (70.5)
PR (>50 to ≤95 %) 18 (42.9) 11 (25.0)
NR (≤50 %) 0 (0.0) 2 (4.5)
Number of treatment sessions (mean ± SD) 1.10 ± 0.30 1.80 ± 0.79 <0.001
1 39 (92.9) 20 (45.5) <0.001
2 3 (7.1) 16 (36.4)
3 0 (0.0) 7 (15.9)
4 0 (0.0) 1 (2.3)
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the acetic acid group, although the protocol consisted of only a single session of scle-
rotherapy, two sessions were performed according to the operators’ decisions in three 
patients. In two of them, sclerotherapy was stopped due to mild flank pain after injection 
of 5–6 mL of acetic acid during the first treatment session. The second session was suc-
cessfully performed the next day without any event. In the other patient, two sessions at 
a 1-day interval were planned and performed due to the operator’s concern regarding 
incomplete sclerotherapy due to the large volume (570 mL) of the cyst. Compared to the 
acetic acid group, the ethanol group patients had higher number of sessions (1.10 ± 0.30 
for the acetic acid group, 1.80 ± 0.79 for the ethanol group, p < 0.001) (Table 2). It was 
also determined that there was no significant linear association between the initial 
calculated volume of the cyst and the volume reduction rate (Spearman’s r = −0.119, 
p = 0.453 in the acetic acid group; r = 0.217, p = 0.156 in the ethanol group).
Mild flank pain was a minor complication that occurred in four patients in the acetic 
acid group and in three patients in the ethanol group during sclerosant injection into the 
cysts. However, there were no major complications in either group. In addition, no addi-
tional complications occurred either on follow-up clinical evaluations or during radio-
logic evaluations.
Discussion
Although there is controversy regarding the best way to treat simple renal cysts using 
sclerotherapy (Egilmez et al. 2007), alcohol is the most commonly used sclerosing mate-
rial for cyst ablation (Amar and Das 1984; Mohsen and Gomha 2005; Ohnishi et al. 1994; 
Cho et al. 2008; Seo et al. 2000; Lin et al. 2005; Akinci et al. 2005; Germani et al. 2010). 
95 %-ethanol is readily available, is inexpensive, and is very slow to penetrate the fibrous 
capsule of a cyst, thus allowing application of the alcohol and its removal before the renal 
parenchyma is affected (Bean 1981). However, in addition to several potential alcohol-
related complications, cyst recurrence has been reported in more than 30 % of patients 
and repeated procedures were required in order to compensate for the decreased effec-
tiveness (Kim et al. 2004; Seo et al. 2000; Hanna and Dahniya 1996).
Acetic acid has a stronger cytotoxic effect than ethanol and produces coagulation 
necrosis (Ohnishi et  al. 1994). Acetic acid received Food and Drug Administration 
(FDA) approval for variety of indications (Won et al. 2004). It is also an economical and 
safe sclerosant (Seo et al. 2000). Ohnishi et al. (1998) showed that acetic acid injection 
is superior to percutaneous ethanol injection in terms of both survival and local recur-
rence rates for small hepatocellular carcinoma in a prospective randomized study. Won 
et al. (2004) assessed the efficacy of percutaneous acetic-acid sclerotherapy for the man-
agement of lymphangiomas. They performed the sclerotherapy procedures with using 
fluoroscopy guidance for 12 lymphangiomas. In that study, the average reduction of the 
cyst volume was 93 % at the end of the first year and the cysts completely disappeared 
in 17 (17.5 %) patients. In their study, complete lymphangioma resolution was obtained 
in eight patients (66.7 %), good resolution (>50 % reduction) was found in three (25 %), 
and poor resolution (<50 % reduction) was seen in one (8.3 %). And except for one, all of 
these patients underwent single-session sclerotherapy.
The first study comparing the effect of acetic acid with ethanol when used for scle-
rotherapy of a simple renal cyst was performed by Seo et al. (2000). In their study, the 
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remaining cysts were examined 4 months after sclerotherapy using acetic acid. The vol-
ume of these cysts was found to be one-half that of the ethanol group. Additionally, the 
acetic acid group had a larger number of cysts that had regressed to <10 % of the initial 
volume than the ethanol group. They performed procedures once for each cyst in both 
groups and concluded that acetic acid is more effective as a sclerosant and induces faster 
regression of a renal cyst than does ethanol. They suggested that if the concentration of 
acetic acid was not decreased to <30 %, it was destructive to the epithelium of the renal 
cyst.
In a study by Cho et al. (2008), they performed one treatment in the acetic-acid group 
and as many as two treatments in the ethanol group. Their study showed that the rates of 
complete remission and partial remission were 90.6 and 9.4 %, respectively, for the acetic 
acid group, and 60 and 30 %, respectively, for the ethanol group, and. The success rate, 
i.e. complete remission and partial remission was found to be significantly higher in the 
acetic-acid group (100.0 %) than in the ethanol group (90 %). In our study, the acetic-acid 
group showed an equivalent sclerosing effect for simple renal cysts with ethanol in terms 
of both the overall and classified regression rates.
While in our study the number of treatment sessions of the 50 %-acetic-acid group was 
significantly fewer than that of the 95 %-ethanol group (p < 0.001), it is one of our study’s 
limitations to have included three patients who underwent two sessions of acetic-acid 
sclerotherapy contrary to the protocol of single acetic-acid sclerotherapy. There was no 
patient who underwent more than two sessions in the acetic-acid group, whereas eight 
patients (18.2 %) underwent more than two sessions in the ethanol group. A small num-
ber of treatment sessions may be an important advantage as multiple sessions are associ-
ated with a risk for infection, patient discomfort, and high cost (Zerem et al. 2008).
Our study has other limitations. First, as the patient evaluation was retrospective, there 
was an unavoidable selection bias. Second, because the type and amount of the sclero-
sant used to perform the treatment were selected according to the operator’s familiarity 
and preference, variable amounts of sclerosants were used. Various concentrations of the 
sclerosants may also have effected the treatment results.
Conclusions
In conclusion, acetic acid seems to have equivalent sclerosing effects on simple renal 
cysts compared with those of ethanol despites of fewer treatment sessions.
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